Dec 15, 2020 / 03:00PM GMT
Operator
Hello, and welcome to the Eurofins Scientific trading update. (Operator Instructions) During this call, Eurofins' management may make forward-looking statements, including, but not limited to, statements with respect to outlook and the related assumption. Management will also discuss alternative performance measures such as organic growth, adjusted EBITDA and free cash flow to the firm, which are defined in the footnotes of our press releases. Actual results may differ materially from objectives discussed. Risks and uncertainties that may affect Eurofins' future results include, but are not limited to, those described in the Risk Factors section of the Eurofins annual report. Please also read the disclaimer on Page 2 of this presentation, subject to which this call and Q&A session are made.
Today, I'm pleased to present that Dr. Gilles Martin, Eurofins' CEO. Please begin.
Gilles G. Martin - Eurofins Scientific SE - Chairman of the Board & CEO
Thank you. Hello, everybody, and thank you for joining our interim Q call. We normally don't announce
October and November 2020 Eurofins Scientific SE Trading Update And Revised Outlook Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot